Prof. Dr. Robin Rumler, country manager of Pfizer Austria, discusses the evolution of their operations, especially since taking over the TBE and meningitis vaccine production plant, as well as the challenges facing the entire Austrian healthcare system today. Furthermore, he provides solutions to create a sustainable future for Austrian healthcare, allowing Pfizer, and the entire pharmaceutical sector, to leverage their innovative world-class treatment options and ensuring patients benefit in the long-term.
We met with you last in 2012, how have your operations evolved since then?
"We are extremely active within industry associations as we do not want to wait for change, but be the ones that help shape the Austrian healthcare ecosystem."
